Results 191 to 200 of about 26,008 (245)

The Neuropsychology of Normal Pressure Hydrocephalus (NPH)

open access: yesBritish Journal of Neurosurgery, 2005
Normal pressure hydrocephalus (NPH) accounts for one of the few known forms of reversible dementia. Varied aetiology and clinical presentation contribute to difficulties with early or differential diagnoses, and delayed surgical treatment may be less efficacious.
Barbara J. Sahakian   +2 more
exaly   +4 more sources

Familial Normal Pressure Hydrocephalus (NPH) With an Autosomal-Dominant Inheritance: A Novel Subgroup of NPH

Journal of the Neurological Sciences, 2011
Normal pressure hydrocephalus (NPH) has two clinical forms: secondary NPH and idiopathic NPH (iNPH). Most patients with NPH occur sporadically: until now, only two families have been reported to have sibling cases of NPH. We here report a large family with 4 patients with elderly-onset NPH in three generations.
Haruo Hanyu   +2 more
exaly   +3 more sources

Theoretical considerations on the pathophysiology of normal pressure hydrocephalus (NPH) and NPH-related dementia

Medical Hypotheses, 2006
Normal pressure hydrocephalus (NPH) is considered to be an example of reversible dementia although clinical improvement after shunting varies from subject to subject, and recent studies have pointed to a possible link with other dementia. The authors consider that the craniospinal compartment is a partially closed sphere with control device systems ...
Abderrahmane, Hamlat   +4 more
openaire   +2 more sources

Shunting for normal pressure hydrocephalus (NPH)

Cochrane Database of Systematic Reviews, 2002
Since the condition was first described in 1965, the syndrome of normal pressure hydrocephalus (NPH) has conventionally been managed by placement of a cerebrospinal fluid (CSF) shunt.To determine the effectiveness of shunting procedures in promoting stability or improvement in the neurological symptoms and signs of NPH.The trials were identified from a
T, Esmonde, S, Cooke
openaire   +2 more sources

USE OF MIXTURES OF NPH AND UNMODIFIED INSULINS

Archives of Internal Medicine, 1951
WITH THE release of NPH insulin for sale on the open market, details concerning its action become of importance to physicians and patients. This new modified protamine insulin is an "intermediate insulin," with a duration of action longer than that of unmodified (crystalline or regular) but shorter than that of protamine zinc insulin.
J W, STEPHENS, R M, DONALDSON, A, MARBLE
openaire   +2 more sources

Clinical experience with NPH insulin

The American Journal of Digestive Diseases, 1954
1. The characteristics of the five types of insulin available and the commonly accepted modes of combining these insulins are briefly reviewed. 2. The advantages of NPH insulin over various combinations and mixtures of protamine zinc insulin with crystalline insulin are discussed. 3.
openaire   +2 more sources

Kinetics of subcutaneous NPH insulin in diabetics

Clinical Pharmacology and Therapeutics, 1982
Kinetics of subcutaneous NPH insulin were studied in newly diagnosed insulin-dependent diabetics. Using a biotelemetric technique with small Geiger-Müller detectors applied to the skin surface, the disappearance of 125I-NPH insulin fron subcutis was monoexponential with a mean half-life of 6.6 +/- 3.3 (SD) hr.
K, Kølendorf, J, Bojsen
openaire   +2 more sources

The Preparation of an Acceptable Placebo for NPH Insulin

Diabetes Care, 1985
A suitable placebo for NPH insulin has not previously been available for clinical investigation. A series of organic and inorganic compounds were formulated as insulin placebos and analyzed according to the following criteria: (1) degree of visual similarity to insulin, (2) stability, (3) absence of local side effects, and (4) clinical safety.
R G, Johnson   +3 more
openaire   +2 more sources

The synthesis and characterization of [TcCl3(NPh)(Ph2PCH2CH2PPh2)] and [TcCl3(NPh)(PPh3)2]. The single crystal X-ray structure of [TcCl3(NPh)(Ph2PCH2CH2PPh2)]

Inorganica Chimica Acta, 1992
Abstract The reaction of (Bu4N)[TcOCl4] in methanol with 1-acetyl-2-phenylhydrazine, followed by 1,2-bis(diphenylphosphino)ethane (DPPE) gives the green technetium(V) phenylimido complex [TcCl3(NPh)(DPPE)]. The IR spectrum of this complex shows a characteristic peak at 1110 cm-1 which is assigned to v(TcN) from the linearly coordinated phenylimido ...
Terrence Nicholson   +4 more
openaire   +1 more source

Comparative Study of NPH Human Insulin (recombinant DNA) and NPH Bovine Insulin in Diabetic Subjects

Diabetes Care, 1982
The hypoglycemic potencies of human insulin (recombinant DNA) and bovine NPH insulin were compared in insulin-dependent diabetic subjects. The same dosages of the two preparations were alternately injected, for two successive 5-day periods, on a twice-a-day schedule. Blood glucose profiles were monitored by finger pricking 6 times/day.
M, Marre   +3 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy